Ceapro (CZO) Stock Chart & Stock Price History → Investors Alert: The Next Big Thing in Weight Loss (From Behind the Markets) (Ad) Free CZO Stock Alerts C$0.24 -0.01 (-2.08%) (As of 10:46 AM ET) Add Compare Share Share ChartStock AnalysisChartEarningsHeadlinesStock AnalysisChartEarningsHeadlines Ceapro Stock Price Performance5 Day Performance-2.08%1 Month Performance+17.50%3 Month Performance+14.63%6 Month Performance-36.49%Year-To-Date Performance+23.68%1 Year Performance-63.85% Receive CZO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ceapro and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsInvestors Alert: The Next Big Thing in Weight LossHistory shows biotech breakthroughs like this can turn small investments into staggering fortunes for those with the foresight to get in early. I've isolated the small company behind it all...The profit window is closing - don't get left behind! CZO Stock Chart for Thursday, March, 28, 2024 CZO Chart by TradingView Ceapro Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/27/2024C$0.24C$0.24-2.08%C$0.24C$0.2365,000 shsC$18.40 million03/26/2024C$0.23C$0.24+4.35%C$0.24C$0.23132,500 shsC$18.79 million03/25/2024C$0.24C$0.23-4.17%C$0.24C$0.23754,000 shsC$18.01 million03/22/2024C$0.24C$0.24C$0.25C$0.242,692 shsC$18.79 million03/21/2024C$0.24C$0.24C$0.24C$0.2417,100 shsC$18.79 million03/20/2024C$0.24C$0.24+2.13%C$0.24C$0.242,140 shsC$18.79 million Get the Latest News and Ratings for CZO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ceapro and its competitors with MarketBeat's FREE daily newsletter. 03/19/2024C$0.25C$0.24-6.00%C$0.24C$0.2458,000 shsC$18.40 million03/18/2024C$0.25C$0.25C$0.25C$0.251,000 shsC$19.57 million03/15/2024C$0.23C$0.25+8.70%C$0.25C$0.251,000 shsC$19.57 million03/14/2024C$0.23C$0.23C$0.23C$0.232,695 shsC$18.01 million03/13/2024C$0.23C$0.23C$0.24C$0.2236,250 shsC$18.01 million03/12/2024C$0.22C$0.23+4.55%C$0.23C$0.2252,506 shsC$18.01 million03/11/2024C$0.23C$0.22-2.22%C$0.23C$0.2236,000 shsC$17.22 million03/08/2024C$0.23C$0.23C$0.23C$0.2248,000 shsC$17.62 million03/07/2024C$0.23C$0.23C$0.23C$0.2295,000 shsC$17.62 million03/06/2024C$0.23C$0.23-2.17%C$0.24C$0.228,390 shsC$17.62 million03/05/2024C$0.24C$0.23-2.13%C$0.23C$0.231,500 shsC$18.01 million03/04/2024C$0.25C$0.24-6.00%C$0.25C$0.245,000 shsC$18.40 million03/01/2024C$0.22C$0.25+13.64%C$0.27C$0.2365,450 shsC$19.57 million02/29/2024C$0.20C$0.22+10.00%C$0.22C$0.2038,703 shsC$17.22 million02/28/2024C$0.21C$0.20-4.76%C$0.21C$0.2054,830 shsC$15.66 million02/27/2024C$0.23C$0.21-8.70%C$0.27C$0.2172,180 shsC$16.44 million02/26/2024C$0.26C$0.23-11.54%C$0.27C$0.22104,225 shsC$18.01 million02/23/2024C$0.17C$0.26+57.58%C$0.27C$0.17369,818 shsC$20.36 million02/22/2024C$0.16C$0.17+3.13%C$0.17C$0.173,500 shsC$12.92 million02/21/2024C$0.17C$0.16-3.03%C$0.17C$0.1629,920 shsC$12.53 million02/20/2024C$0.17C$0.17C$0.17C$0.179,000 shsC$12.92 million02/19/2024C$0.17C$0.17C$0.18C$0.1760,485 shsC$12.92 million02/16/2024C$0.18C$0.17-8.33%C$0.18C$0.1760,485 shsC$12.92 million02/15/2024C$0.18C$0.18C$0.18C$0.1833,000 shsC$14.09 million02/14/2024C$0.16C$0.18+12.50%C$0.18C$0.1833,000 shsC$14.09 million02/13/2024C$0.17C$0.16-5.88%C$0.16C$0.161,924 shsC$12.53 million02/12/2024C$0.18C$0.17-2.86%C$0.17C$0.1726,500 shsC$13.31 million02/09/2024C$0.17C$0.18+2.94%C$0.18C$0.181,900 shsC$13.70 million02/08/2024C$0.15C$0.17+13.33%C$0.18C$0.1626,500 shsC$13.31 million02/07/2024C$0.15C$0.15C$0.17C$0.1530,700 shsC$11.74 million02/06/2024C$0.16C$0.15-6.25%C$0.17C$0.1530,700 shsC$11.74 million02/05/2024C$0.17C$0.16-5.88%C$0.17C$0.167,000 shsC$12.53 million02/02/2024C$0.16C$0.17+6.25%C$0.17C$0.171,500 shsC$13.31 million02/01/2024C$0.17C$0.16-3.03%C$0.17C$0.162,900 shsC$12.53 millionInvestors Alert: The Next Big Thing in Weight Loss (Ad)History shows biotech breakthroughs like this can turn small investments into staggering fortunes for those with the foresight to get in early. I've isolated the small company behind it all...The profit window is closing - don't get left behind!01/31/2024C$0.18C$0.17-5.71%C$0.17C$0.172,000 shsC$12.92 million01/30/2024C$0.16C$0.18+12.90%C$0.18C$0.168,500 shsC$13.70 million01/29/2024C$0.16C$0.16-3.13%C$0.17C$0.1615,350 shsC$12.14 million01/26/2024C$0.16C$0.16C$0.16C$0.166,000 shsC$12.53 million01/25/2024C$0.16C$0.16C$0.16C$0.1617,201 shsC$12.53 million01/24/2024C$0.17C$0.16-3.03%C$0.16C$0.1617,201 shsC$12.53 million01/23/2024C$0.17C$0.17C$0.17C$0.1711,861 shsC$12.92 million01/22/2024C$0.17C$0.17C$0.17C$0.166,700 shsC$12.92 million01/19/2024C$0.16C$0.17+3.13%C$0.17C$0.166,700 shsC$12.92 million01/18/2024C$0.17C$0.16-3.03%C$0.17C$0.1537,500 shsC$12.53 million01/17/2024C$0.18C$0.17-5.71%C$0.18C$0.1750,450 shsC$12.92 million01/16/2024C$0.19C$0.18-7.89%C$0.19C$0.1734,042 shsC$13.70 million01/15/2024C$0.19C$0.19C$0.19C$0.195,000 shsC$14.88 million01/12/2024C$0.19C$0.19+2.70%C$0.19C$0.1811,049 shsC$14.88 million01/11/2024C$0.18C$0.19+2.78%C$0.19C$0.1920,000 shsC$14.48 million01/10/2024C$0.18C$0.18C$0.18C$0.183,500 shsC$14.09 million01/09/2024C$0.18C$0.18C$0.18C$0.185,000 shsC$14.09 million01/08/2024C$0.18C$0.18C$0.18C$0.185,000 shsC$14.09 million01/05/2024C$0.18C$0.18C$0.18C$0.187,500 shsC$14.09 million01/04/2024C$0.19C$0.18-2.70%C$0.19C$0.187,500 shsC$14.09 million01/03/2024C$0.18C$0.19+5.71%C$0.19C$0.192,325 shsC$14.48 million01/02/2024C$0.19C$0.18-7.89%C$0.19C$0.1862,025 shsC$13.70 million01/01/2024C$0.19C$0.19C$0.21C$0.1963,333 shsC$14.88 million12/29/2023C$0.21C$0.19-7.32%C$0.21C$0.1963,333 shsC$14.88 million12/28/2023C$0.21C$0.21C$0.21C$0.2132,700 shsC$16.05 million12/27/2023C$0.20C$0.21+2.50%C$0.21C$0.2042,262 shsC$16.05 million Related Companies: Sirona Biochem Stock Price Chart Resverlogix Stock Price Chart Antibe Therapeutics Stock Price Chart Aeterna Zentaris Stock Price Chart Kane Biotech Stock Price Chart Hemostemix Stock Price Chart Devonian Health Group Stock Price Chart Aptose Biosciences Stock Price Chart Covalon Technologies Stock Price Chart IBEX Technologies Stock Price Chart Receive CZO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ceapro and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:CZO) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryMost important medical advance in 100 yearsThe Oxford ClubFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ceapro Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.